Chromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins

Biochemical and Biophysical Research Communications

Volumn 313, Issue 3, 2004, Pages 654-665

  Nagaraja, Ganachari M ^a   Kandpal, Raj P ^a  

^a FORDHAM UNIVERSITY   (United States)

Author keywords

Breast carcinoma: RhoGAP interacting proteins; Chromosome 13: RhoGAP; Growth inhibition; Rho signaling

Indexed keywords

ALPHA TUBULIN; COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HYBRID PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPID TRANSFER PROTEIN; PROTEIN CDC42; PROTEIN P21; PROTEIN SWI; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TAX PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL GROWTH; CELL PROLIFERATION; CHROMOSOME 13Q; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; GENE ISOLATION; GENE MAPPING; GENE SEQUENCE; GENE STRUCTURE; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; STRESS FIBER; TWO HYBRID SYSTEM;

EID: 0345802686     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.001     Document Type: Article

References (64)

1. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics. CA Cancer J. Clin. 53:2003;5-26.
2. Miki Y., Swensen J., Shattuck-Edens D., Futreal P.A., Harshman K., Tavtgian S., Liu Q., Cochran C.et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
3. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregorg S., Gumbs C., Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789-792.
4. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature. 411:2001;342-348.
5. Hahn W.C., Weinberg R.A. Rules for making human tumor cells. New Engl. J. Med. 347:2003;1593-1603.
6. Triche T.J., Schofield D., Buckley J. DNA microarrays in pediatric cancer. Cancer J. 7:2001;2-15.
7. Chakraborty S., Senyuk V., Nucifora G. Genetic lesions and perturbation of chromatin architecture: a road to cell transformation. J. Cell. Biochem. 82:2001;310-325.
8. Jacob A.N.K., Kandpal G., Kandpal R.P. Isolation of expressed sequences that include a gene for familial breast cancer (BRCA2) and other novel transcripts from a five megabase region on chromosome 13q12. Oncogene. 13:1996;213-221.
9. Symons M. rho family GTPases: the cytoskeleton and beyond. Trends Biochem. Sci. 21:1996;178-181.
10. Etienne-Manneville S., Hall A. Rho GTPases in cell biology. Nature. 420:2002;629-635.
11. Pruitt K., Der C. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett. 171:2001;1-10.
12. Bos J.L. Ras oncogenes in human cancer. Cancer Res. 49:1989;4682-4689.
13. Khosravi-Far R., Der C.J. The Ras signal transduction pathway. Cancer Metastasis Rev. 13:1994;67-89.
14. Midgley R.S., Kerr D.J. Ras as a target in cancer therapy. Crit. Rev. Oncol. Hematol. 44:2002;109-120.
15. Malaney S., Daly R.J. The ras signaling pathway in mammary tumorigenesis and metastasis. J. Mammary Gland Biol. Neoplasia. 6:2001;101-113.
16. Evers E.E., van der Kammen R.A., ten Klooster J.P., Collard J.G. Rho-like GTPases in tumor cell invasion. Methods Enzymol. 325:2000;403-415.
17. Schmitz A.A., Govek E.E., Bottner B., Van Aelst L. Rho GTPases: signaling, migration, and invasion. Exp. Cell. Res. 261:2000;1-12.
18. Frame M.C., Brunton V.G. Advances in Rho-dependent actin regulation and oncogenic transformation. Curr. Opin. Genet. Dev. 12:2002;36-43.
19. Bishop A.L., Hall A. Rho GTPases and their effector proteins. Biochem. J. 348:2000;241-255.
20. Peck J., Douglas IV G., Wu C.H., Burbelo P.D. human RhoGAP domain-containing proteins: structure, function and evolutionary relationships. FEBS Lett. 528:2002;27-34.
21. Bernards A. GAPs galore! A survey of putative Ras super family GTPase activating proteins in man and Drosophila. Biochim. Biophys. Acta. 1603:2003;47-82.
22. Ching Y.P., Wong C.M., Chan S.F., Leung T.H., Ng D.C., Jin D.Y., Ng I.O. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J. Biol. Chem. 278:2003;10824-10830.
23. Parimoo S., Patanjali S.R., Shukla H., Chaplin D.D., Weissman S.M. cDNA selection: efficient PCR approach for the selection of cDNAs encoded in large chromosomal DNA fragments. Proc. Natl. Acad. Sci. USA. 88:1991;9623-9627.
24. Feinberg A.P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:1983;6-13.
25. Church G.M., Gilbert W. Genomic sequencing. Proc. Natl. Acad. Sci. USA. 81:1984;1991-1995.
26. Self A.J., Hall A. Measurement of intrinsic nucleotide exchange and GTP hydrolysis rates. Methods Enzymol. 256:1995;67-76.
27. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
28. Lundberg C., Skoog L., Cavenee W., Nordenskjold M. Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome13. Proc. Natl. Acad. Sci. USA. 84:1987;2372-2376.
29. Collins N., Mc Manus R., Wooster R., Mangion J., Seal S., Lakhani S.R., Ormiston W., Daly P.A., Ford D., Easton D.F.et al. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene. 10:1995;1673-1675.
30. Gudmundsson J., Johannesdottir G., Bergthorsson J.T., Arason A., Ingvarsson S., Eglisson V., Barkardottir R.B. Different tumor types from BRCA2 carriers show wild type chromosome deletions on 13q12-q13. Cancer Res. 55:1995;4830-4832.
31. Kuroki T., Fujiwara Y., Nakamori S., Imaoka S., Kanematsu T., Nakamura Y. Evidence for the presence of two tumor-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br. J. Cancer. 72:1995;383-385.
32. Schutte M., da Costa L.T., Hahn S.A., Moskaluk C., Hoque A.T., Rozenblum E., Weinstein C.L., Bittner M., Meltzer P.S., Trent J.M. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc. Natl. Acad. Sci. USA. 92:1995;5950-5954.
33. Schutte M., Rozenblum E., Moskaluk C., Guan X., Hoque A.T., Hahn S.A., da Costa L.T., de Jong P.J., Kern S.E. An integrated high-resolution physical map of the DPC/BRCA2 region at chromosome 13q12. Cancer Res. 55:1995;4570-4574.
34. Mareel M., Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 83:2003;337-376.
35. Hedenfalk I.A., Ringer M., Trent J.M., Borg A. Gene expression in inherited breast cancer. Adv. Cancer Res. 84:2002;1-34.
36. Lerebours F., Lidereau R. Molecular alterations in sporadic breast cancer. Crit. Rev. Oncol. Hematol. 44:2002;121-141.
37. Miyakis S., Sourvinos G., Spandidos D.A. Differential expression and mutation of the ras family genes in human breast cancer. Biochim. Biophys. Res. Commun. 251:1998;609-612.
38. Sahai E., Ishizaki T., Narumiya S., Treisman R. Transformation mediated by RhoA requires activity of ROCK kinases. Curr. Biol. 9:1999;136-145.
39. Bar-Sagi D., Hall A. Ras and Rho GTPases: a family reunion. Cell. 103:2000;227-238.
40. Sahai E., Olson M.F., Marshall C.J. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 20:2001;755-766.
41. Chen J.C., Zhuang S., Nguyen T.H., Boss G.R., Pilz R.B. Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity. J. Biol. Chem. 278:2003;2807-2818.
42. Zohn I.M., Campbell S.L., Khosravi-Far R., Rossman K.I., Der C.J. Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene. 17:1998;1415-1438.
43. Fritz G., Just I., Kaina B. Rho GTPases are over-expressed in human tumors. Int. J. Cancer. 81:1999;682-687.
44. Denoyelle C., Albanese P., Uzan G., Hong L., Vannier J.P., Soria J., Soria C. Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells. Cell. Signal. 15:2003;327-338.
45. Ponting C.P., Aravind L. START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins. Trends Biochem. Sci. 24:1999;130-132.
46. Christenson L.K., Strauss J.F. Steroidogenic acute regulatory protein (StAR) and the intramitochondrial translocation of cholesterol. Biochim. Biophys. Acta. 1529:2000;175-187.
47. Lin D., Sugawara T., Strauss J.F., Clark B.J., Stocco D.M., Saenger P., Rogol A., Miller W.L. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science. 267:1995;1828-1831.
48. Bose H., Sugawara T., Strauss J.F., Miller W.L. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International congenital lipoid adrenal hyperplasia consortium. New Engl. J. Med. 335:1996;1870-1878.
49. Nakae J., Tajima T., Sugawara T., Arakane F., Hanaki K., Hotsubo T., Igarashi N., Igarashi Y., Ishii T., Koda N., Kondo T., Kohno H., Nakagawa Y., Tachibana K., Takeshima Y., Tsubouchi K., Strauss III J.F., Fujieda K. Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congenital lipoid adrenal hyperplasia. Hum. Mol. Genet. 6:1997;571-576.
50. Thanos C.D., Goodwill K.E., Bowie J.U. Oligomeric structure of the human EphB2 receptor SAM domain. Science. 283:1999;833-836.
51. ′ -untranslated region of mRNA molecules specifying inflammatory mediators Proc. Natl. Acad. Sci. USA. 83:1986;1670-1674.
52. ′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation Cell. 46:1986;659-667.
53. Wang W., Xue Y., Zhou S., Kuo A., Cairns B.R., Crabtree G.R. Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev. 10:1996;2117-2130.
54. Kitamura T., Kawashima T., Minoshima Y., Tonuzuka Y., Hirose K., Nosaka T. Role of MgcRacGAP/Cyk4 as a regulator of the small GTPase Rho family in cytokinesis and cell differentiation. Cell. Struct. Funct. 26:2001;645-651.
55. Bochar D.A., Wang L., Beniya H., Kinev A., Xue Y., Lane W.S., Wang W., Kashanchi F., Shiekhattar R. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell. 102:2000;257-265.
56. Davis P.K., Brackmann R.K. Chromatin remodeling and cancer. Cancer Biol. Ther. 2:2003;22-29.
57. Ohta S., Nishio K., Kubota N., Ohmori T., Funayama Y., Ohira T., Nakajima H., Adachi M., Sajio N. Characterization of a taxol-resistant human small-cell lung cancer cell line. Jpn. J. Cancer Res. 85:1994;290-297.
58. Lafanechere L., Courtay-Cahen C., Kawakami T., Jacrot M., Rudiger M., Wehland J., Job D., Margolis R.L. Suppression of tubulin tyrosine ligase during tumor growth. J. Cell Sci. 111:1998;171-181.
59. Kyu-Ho Han E., Gehrke L., Tahir S.K., Credo R.B., Cherian S.P., Sham H., Rosenberg S.H., Ng S. Modulation of drug resistance by alpha-tubulin in paclitaxel-resistant human lung cancer cell lines. Eur. J. Cancer. 36:2000;1565-1571.
60. Banerjee A. Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Biochim. Biophys. Res. Commun. 293:2002;598-601.
61. Alexandrova N., Niklinski J., Bliskovsky V., Otterson G.A., Blake M., Kaye F.J., Zajac-Kaye M. The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. Mol. Cell. Biol. 15:1995;5188-5195.
62. Yoshida M. HTLV-1 Tax: regulation of gene expression and disease. Trends Microbiol. 1:1993;131-135.
63. Pozzati R., Vogel J., Jay G.A. The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cell. Mol. Cell. Biol. 10:1990;413-417.
64. De Valck D., Jin D.Y., Heyninck K., Van de Craen M., Contreras R., Fiers W., Jeang K.T., Beyaert R. The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases. Oncogene. 18:1999;4182-4190.